228 related articles for article (PubMed ID: 32129669)
1. Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure.
Miñana G; de la Espriella R; Mollar A; Santas E; Núñez E; Valero E; Bodí V; Chorro FJ; Fernández-Cisnal A; Martí-Cervera J; Sanchis J; Bayés-Genís A; Núñez J
Eur Heart J Acute Cardiovasc Care; 2020 Aug; 9(5):437-447. PubMed ID: 32129669
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
[TBL] [Abstract][Full Text] [Related]
3. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
4. Independent prognostic value of echocardiography and N-terminal pro-B-type natriuretic peptide in patients with heart failure.
Hinderliter AL; Blumenthal JA; O'Conner C; Adams KF; Dupree CS; Waugh RA; Bensimhon D; Christenson RH; Sherwood A
Am Heart J; 2008 Dec; 156(6):1191-5. PubMed ID: 19033018
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure.
Chen X; Wu M; Xu K; Huang M; Zhuo X
Acta Cardiol; 2021 Feb; 76(1):87-92. PubMed ID: 32519930
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure.
Yoon JY; Yang DH; Cho HJ; Kim NK; Kim CY; Son J; Roh JH; Jang SY; Bae MH; Lee JH; Park HS; Cho Y; Chae SC
Korean J Intern Med; 2019 Jul; 34(4):811-818. PubMed ID: 30616330
[TBL] [Abstract][Full Text] [Related]
7. Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.
Verdú JM; Comín-Colet J; Domingo M; Lupón J; Gómez M; Molina L; Casacuberta JM; Muñoz MA; Mena A; Bruguera-Cortada J
Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):613-9. PubMed ID: 22541282
[TBL] [Abstract][Full Text] [Related]
8. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
9. Serial Measurement of Amino-Terminal Pro-B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Outcome in Children With Primary Myocardial Dysfunction and Acute Decompensated Heart Failure.
Medar SS; Hsu DT; Ushay HM; Lamour JM; Cohen HW; Killinger JS
Pediatr Crit Care Med; 2015 Jul; 16(6):529-34. PubMed ID: 25856472
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
11. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
Park M; Vittinghoff E; Shlipak MG; Mishra R; Whooley M; Bansal N
Am Heart J; 2014 Dec; 168(6):931-9.e2. PubMed ID: 25458658
[TBL] [Abstract][Full Text] [Related]
12. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
13. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
[TBL] [Abstract][Full Text] [Related]
14. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.
Stanciu AE; Stanciu MM; Vatasescu RG
Cytokine; 2018 Nov; 111():13-19. PubMed ID: 30098475
[TBL] [Abstract][Full Text] [Related]
15. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
17. [Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure].
Manzano-Fernández S; Januzzi JL; Boronat García M; Bonaque-González JC; Muñoz-Esparza C; Albaladejo-Otón MD; Pastor-Pérez FJ; Pastor P; Valdés M; Pascual-Figal DA
Rev Esp Cardiol; 2011 May; 64(5):365-72. PubMed ID: 21397374
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.
Jafri L; Kashif W; Tai J; Siddiqui I; Azam I; Shahzad H; Ghani F
BMC Nephrol; 2013 May; 14():117. PubMed ID: 23725445
[TBL] [Abstract][Full Text] [Related]
19. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
[TBL] [Abstract][Full Text] [Related]
20. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
